Oregon DUR Newsletter

The Drug Use Review Newsletters are now available online in two formats:

• The PDF files are scanned reproductions of the print version of the newsletter. To view or print a PDF file requires Acrobat Reader, which is free to download. When you have completed downloading Acrobat Reader, use the "Back" feature on your browser to return here. The PDF versions of newsletters are 2 to 8 pages long and 1-5 MB in size.
• The newsletters are also available in HTML format. These copies are viewable in your browser and are complete articles, however they lack the formatting of the original newsletters.

Volume 4 - 2002
Issue		Table of Contents		PDF
No. 10, Dec. 2002		- Combination Hormonal Contraception Options Reviewed - Lunelle Recall
No. 9, Nov. 2002		The Role of Advair for Treatment of Asthma and COPD
No. 8, Oct. 2002		Carisoprodol (Soma) and Sedative Quantities to be Restricted on November 15, 2002
No. 7, Sept. 2002		Zelnorm®: What is the evidence of benefit for IBS?
No. 6, August 2002		Fluoroquinolones in Outpatient Infections: Friend or Foe?
No. 5, July 2002		Pharmacotherapy for Overactive Bladder: Oxybutynin vs. Tolterodine
No. 4, June 2002		HRC Reports Evidence in First Classes for OHP Drug Plan
No. 3, May 2002		- Long-Acting Opioids: A Second Glance - Depakote ER® for Depakote® Errors Noted
No. 2, April 2002		A Review of Stimulant Medications
No. 1, March 2002		- Lipid Treatment News - The OHP Practitioner-Managed Prescription Drug Plan

Copyright 2006
Oregon State University
All Rights Reserved

Oregon State University grants permission to use this newsletter for noncommercial educational and research purposes only. The copyright and this grant of permission do not allow the use of the name of Oregon State University to be used in any advertising or publicity pertaining to the use of this newsletter without specific written prior authorization from the OSU College of Pharmacy.